Naoya Kato, MSc

CEO & Representative Director, IDEC


Mr. Kato has more than 30 years’ experience working at large multi-national pharmaceutical companies, including Roche and Amgen.

regulatory science for the development of global product development strategies. Mr. Kato achieved several successful globally-integrated programs involving Japan by leading global project teams through PMDA consultations and clarifying the regulatory requirements for Japanese submissions—including CTNs and Japanese NDAs—for global product development programs.

Ready for regulatory clarity? Contact us.